Hot of the Press February 2026

Article to ponder

This systematic review of five randomized controlled trials (1004 participants) examined whether prophylactic compression sleeves prevent breast cancer–related lymphedema after axillary surgery. The review found no significant reduction in lymphedema incidence with sleeve use compared with standard care, although some studies reported small, inconsistent reductions in early arm swelling. Evidence quality was low due to heterogeneity, variable adherence, and risk of bias, and no sustained quality-of-life benefits were demonstrated

Compression sleeves for prevention and treatment of breast cancer-related lymphedema: a systematic review and meta-analysis

Haifeng Cheng, Jianmei Gong, Lin Yu, Xiaoyu Feng, Wenna Ou, Huan Wang, Hongjing Zhong, En Ming Zhang. Breast Cancer Res Treat. 2025 Dec 13.

Download full paper

Key Takeaway: Prophylactic compression sleeves do not meaningfully reduce the incidence of breast cancer–related lymphedema, although they may confer small, short-term reductions in arm swelling, based on low-certainty evidence.

We have collated some great articles and material published over the last month. Click on the links below to read the  abstract or download the full paper.

Anatomy / Physiology /Pathophysiology

Ultrasonographic Evaluation of Distal Femoral Cartilage Thickness in Patients with Lower Extremity Lymphedema

Ömer Kuzu, Gonca Canan Doğan Tosun, Berke Aras, Bilge Özlemiş, Tuğba Kara, Pınar Borman. Lymphat Res Biol. 2025 Dec 4..1177/1557 858 52.

Background: Cartilage thickness has been evaluated in many diseases, and its relationship with osteoarthritis has been investigated. However, the effect of lower extremity lymphedema on knee joint cartilage has not been well investigated. This study aimed to evaluate the distal femoral cartilage thickness ultrasonographically in patients with unilateral lower extremity lymphedema and to investigate its relationship with clinical features.
Methods and Results: This cross-sectional study included 27 patients (mean age: 49.56 ± 12.06 years; 92.6% female) with unilateral lower extremity lymphedema. Distal femoral cartilage thickness of both knees was measured at the medial condyle, lateral condyle, and intercondylar notch by using ultrasound. Functional status and quality of life were assessed with the Lower Extremity Functional Scale and Lymphedema Quality of Life Questionnaire, respectively. The mean intercondylar notch cartilage was significantly thinner on the lymphedema side compared to the contralateral side (2.03 ± 0.41 mm vs. 2.24 ± 0.58 mm, p < 0.05). Although the medial (1.96 ± 0.36 mm vs. 2.04 ± 0.42 mm) and lateral (1.90 ± 0.37 mm vs. 2.03 ± 0.41 mm) condyles were also thinner on the affected side, they were not statistically significant (p > 0.05). No significant correlations were identified between distal femoral cartilage thickness at the intercondylar notch and clinical features, functionality, and quality of life (p > 0.05).
Conclusions: This study showed that distal femoral cartilage thickness, particularly at the intercondylar notch, is thinner in the affected limbs of patients with unilateral lower extremity lymphedema. These findings suggest that knee joint cartilage integrity may be affected in patients with lower extremity lymphedema and that ultrasonographic evaluation may be useful in this regard.:10.1177/15578585251404488

The Upper Arm Lymphosome: Watershed of Upper Arm Lymphatic Pathways Evaluated with Indocyanine Green Lymphography

H Sakai, T Miyazaki, R Tsukuura, T Yamamoto, Lymphology. 2025.

Understanding lymphatic anatomy of the upper extremity is necessary for treatment of upper extremity lymphedema (UEL). This study aimed to clarify the watershed of upper arm lymphosomes using fluorescent lymphography with multi-site injection of indocyanine green (ICG). Limbs contralateral to breast cancer treatment side of breast cancer survivors were included to evaluate upper arm lymphosomes. 0.1ml of ICG was injected intra-dermally at these 3 points in the mid-lateral upper arm: at the level of one (U1), two (U2), and three quarters (U3) from the lateral edge of the acromion to the lateral epicondyle of the humerus. Fluorescent images were obtained to determine the upper arm lymphatic pathway patterns. An injection site with multiple lymphatic pathways was evaluated as a watershed point. A total of twenty-one limbs were included. The lymphatic pathways from the U1/ U2/ U3 were anteromedial patterns in 20/13/6 (95.2%/90.5%/28.6%), and posterolateral pat-terns in 3/13/19 (14.3%/61.9%/90.5%), respectively. Both patterns were identified in 2/12/5 (9.5%/57.1%/23.8%), and no pattern in 0/1/1 (0%/4.8%/4.8%). Based on study results, the true watershed was determined as an approximate line from the posterolateral side of the lateral edge of the acromion to the anteromedial side of the lateral epicondyle of the humerus rather than a mid-arm line.

Definition, Epidemiology and Pathophysiology of Lymphoedema

Erich Brenner, René Hägerling, Vivien Schacht, Klaus Schrader, Jörg Wilting. Cells. 2025 Dec 9

Download full paper

Indocyanine Green Lymphography Imaging of Normal Lymphatic Drainage in the Lower Limbs

Mike Mills, Malou van Zanten, Greta Brezgyte, Bernard Ho, Julian Pearce, Stephanie Wilken-Smith, Manan Shelton, Peter S. Mortimer, Hiroo Suami, Kristiana Gordon, Pia Ostergaard. Br J Radiol. 2026 Jan 10.

Download full paper

Prevalence and Risk Factors

Patients With Lymphedema are at Increased Risk of Complication After Total Knee Arthroplasty: A Population Level Study

Bryce T. Hrudka, Evan Bailey, Alyssa Woltemath, Grayson Nour, Ajay Premkumar, Jacob M. Wilson. Arthroplast Today. 2025 Nov 21. Dec

Download full paper

Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients

Miaomiao Jia, Lihui Pan, Haibo Yang, Jinnan Gao, Wenzhuang Shen, Xiaojun Zhang. Front Oncol. 2025 Nov 21.

Download full paper

Machine learning-based personalized risk prediction model for breast cancer-related lymphedema after surgery

Xuemei Peng, Yanfang Ai, Weiying Xu, Jingling Hong, Qinyan Li, Jianfen Liu. Front Oncol. 2025 Dec 4

Download full paper

Limb swelling consistent with posttraumatic lymphedema after closed upper and lower extremity fractures: A retrospective cohort study

Felix Reinkemeier, Christoph Wallner, Marius Drysch, Sonja Verena Schmidt, Flemming Puscz, Maxi von Glinski, Thomas Armin Schildhauer, Marcus Lehnhardt, Björn Behr, Johannes Maximilian Wagner. PLoS One. 2025 Dec 11

Download full paper

Prevention of arm lymphoedema after breast cancer: what health professionals need to know

Sinead Cobbe, Kathy Nugent. Br J Community Nurs. 2025 Dec 2.

Arm lymphoedema after breast cancer treatment is preventable and can be reversible if caught early. Many risk factors are modifiable and lifestyle changes adopted by patients can reduce incidence substantially. Education in risk reduction is a central tenet of specialist lymphoedema prevention programmes, however, non-specialist healthcare professionals commonly get requests for instructions and advice by breast cancer patients. In general, healthcare professionals receive inadequate education and training on the lymphatic system and may feel ill-equipped to issue advice, despite being best placed to provide it. Low-risk patients are unlikely to require lifestyle modifications to prevent lymphoedema once the treatment phase is over, unless cording or adherent axillary scars persist, but high- and medium-risk patients need education in lifetime prevention and self-treatment strategies. This article discusses risk stratification and outlines self-management strategies for at-risk cohorts. By gaining knowledge about lymphoedema prevention, healthcare professionals can confidently guide their patients on how to prevent lymphoedema and its physical and psychological sequelae.:10.12968.0134
Key Points

Why It Matters

  • Arm lymphoedema occurs in ~20% of breast cancer patients after surgery or radiotherapy.
  • It significantly impacts quality of life, increases risk of cellulitis, and leads to higher healthcare utilization.
  • Psychological burden includes negative self-identity and social isolation.

Prevention and Early Detection

  • Lymphoedema is preventable and reversible if detected early.
  • Monitoring every 3–6 months for 2–3 years post-treatment reduces incidence.
  • Tools: bioimpedance spectroscopy or circumferential measurements.
  • Education on lifestyle changes and self-management strategies is critical.

Risk Factors

  • Baseline risk:
    • High risk: Full axillary clearance ± radiotherapy (up to 38.7% incidence).
    • Medium risk: Partial clearance or targeted axillary radiotherapy (~11%).
    • Low risk: Sentinel node biopsy (<5 nodes removed, ~5.6%).
  • Additional treatment factors: infections, seromas, cording, mastectomy, chemotherapy ports, hormonal therapy.
  • Lifestyle factors: high BMI, sedentary lifestyle, injuries, inflammation.

Updated Advice

  • Exercise, including resistance training, is now recommended (activates muscle pump).
  • Avoid unnecessary restrictions; encourage normal arm use.
  • Prevent cuts, burns, bites; maintain skin care to reduce cellulitis risk.

Preventative Strategies (Table 3)

  • Arm exercises and general physical activity.
  • Maintain healthy weight.
  • Deep breathing exercises.
  • Mobilise and stretch tight scars.
  • Treat cording promptly.
  • Use compression sleeves as needed.
  • Good skin care and moisturising.
  • Prepare for long-haul flights (movement, hydration, optional sleeve).

Role of Community Health Professionals

  • Provide lifetime education for medium/high-risk patients.
  • Reinforce advice at multiple time points (due to stress and poor retention).
  • Empower patients to self-monitor and self-manage early swelling episodes.

Key Takeaways

  • Arm lymphoedema is preventable and reversible if caught early.
  • Education and monitoring are central to prevention.
  • High- and medium-risk patients need ongoing support and self-management skills.
  • Community professionals play a critical role in prevention and early intervention.

A Latent Profile Analysis of Risk Perception in Breast Cancer-Related Lymphedema Among Women With Breast Cancer

Yuqing Wu, Zhuyue Ma, Yanyan Shi, Shanshan Yao, Mingyao Zhou, Fang Cheng. Int J Nurs Pract. 2025 Dec 31.

BACKGROUND: Breast cancer-related lymphedema (BCRL) is a common postoperative complication that impairs arm function and diminishes quality of life. Consistent engagement in self-management practices is crucial for the early prevention of BCRL. Since risk perception is a key determinant of behaviour change, it may serve as a critical target for improving adherence to BCRL self-management among patients with breast cancer. This research aimed to evaluate the profiles and determinants of risk perception related to BCRL in women after breast cancer surgery.
METHODS: A cross-sectional study involving 211 patients with breast cancer was carried out. Participants were recruited using convenience sampling from a tertiary hospital in Nanjing. Data were collected using a general information questionnaire, a self- designed and validated risk perception questionnaire, a lymphedema-related knowledge questionnaire, the Perceived Social Support Scale, and the General Self-Efficacy Scale. Latent profile analysis was carried out to determine subgroups of risk perception related to BCRL. Univariate and multivariate analyses were employed to examine factors influencing these subgroups.
RESULTS: Latent profile analysis revealed three distinct risk perception subgroups: low-level risk perception (18.0%), medium-level risk perception (39.8%), and high-level risk perception (42.2%). Multinomial logistic regression revealed that factors such as age, employment status, education level, monthly household income, type of breast surgery, lymphedema-related knowledge, perceived social support, and self-efficacy significantly influenced these risk perception profiles (p < 0.05).
CONCLUSIONS: Substantial heterogeneity exists in risk perception levels regarding BCRL among patients with breast cancer after surgery. Healthcare providers should prioritize early identification of patients with low-risk perception tendencies and implement targeted interventions to address misperceptions. These efforts could enhance adherence to preventive strategies and mitigate the risk of BCRL.:10.1111

Assessment

Assessing Tissue Dielectric Constant Values in Tumor Bearing and Healthy Breasts

Harvey N. Mayrovitz, Mary Beth Tomaselli. Lymphat Res Biol. 2024 Dec 10. 

Background: This study aimed to investigate, characterize, and provide quantitative reference data on tissue dielectric constant (TDC) values of female breasts when measurements were made to 5 mm depths and determine the utility of these measurements to differentiate between benign and malignant breast tumors.

Methods and Results: Breast TDC was measured bilaterally in 82 women just prior to an ultrasound-guided diagnostic biopsy of one tumor in one breast. TDC was measured in triplicate over the tumor and the contralateral healthy breast. Considering all paired breasts, the average TDC (mean ± SD) for healthy breasts was less than for tumor-bearing breasts (26.7 ± 4.5 vs. 29.9 ± 8.5, p = 0.0003).

Conclusions: Breast TDC values measured to 5 mm in 82 healthy nonedematous breasts provide a two-SD threshold reference value of 35.7. This represents a TDC value above which the presence of breast edema/lymphedema may be indicated based on the two-SD threshold criterion. For unilateral cases, an interbreast TDC ratio exceeding 1.275 may be considered a breast edema/lymphedema indicator also based on the two SD criteria used. These thresholds may have utility for early detection and to track breast edema/lymphedema changes. A comparison of these TDC values obtained from benign versus malignant tumors indicates no statistically significant difference between them. However, interbreast TDC ratios were statistically higher for breasts with malignant versus benign tumors. However, the large overlap of the ratio values renders this method of discrimination between benign vs. malignant tumors inadequate based on the present findings.:10.1089.0061

Hyperspectral imaging as an objective diagnostic tool for secondary lymphedema in breast cancer patients

Martin Weiss, Ovidiu Jurjuț, Astrid Ehrhardt, Anaclara Herholz, Anna Seller, Adrien Daigeler, Markus Hahn, Mario Marx, Lukas Schimunek, Wiebke Eisler. Commun Med (Lond). 2025 Dec 18

Download full paper

Impact of Breast Cancer-Related Lymphedema on Cancer Care Costs: Longitudinal and Age-Based Analyses

Anne Marie Raymakers, Tari A. King, Elizabeth A. Mittendorf, Tanujit Dey, Mahima Jain, Electra D. Paskett, Ann S. McAlearney, Rachel A. Greenup, Justin M. Broyles, Sara P. Myers. Ann Surg Oncol. 2025 Dec 16

Download full paper

Inter-breast Ratios of Tissue Dielectric Constant Values to Detect and Track Unilateral Breast Edema or Lymphedema

Harvey N. Mayrovitz Cureus. 2025 Nov 24. 

Download full paper

Management Strategies

Finite Element Modeling of Compression Therapy in Lower Limb Lymphedema

Mateus Américo de Almeida, Aratz García-Llona, Maha Reda, Stéphane Avril. Int J Numer Method Biomed Eng. 2025 Dec 41.

Patients with lower limb lymphedema experience lymphatic fluid accumulation and swelling, which can progress to fibrosis and fat deposition in the soft tissues, impacting patients physically, socially, and psychologically. Compression therapy is one of the main treatments for lymphedema, but its effects on lymphedematous soft tissues are not yet fully understood. In this study, we developed a finite element model of a lymphedematous leg including subcutaneous and muscle tissues, as well as skin and fascia cruris, to investigate the hydrostatic pressure distribution resulting from the interface pressure applied by a compression stocking. The results highlight the significant influence of the leg’s external geometry on the interface pressure, and demonstrate the importance of modeling skin to accurately predict hydrostatic pressure distribution in the subcutaneous tissue, with a 3.5% reduction in leg volume observed after compression. The outcomes improve the understanding of the effects of compression therapy on lower limbs affected by lymphedema and support the development of adapted treatment strategies for patients.:10.1002

Effects of Aerobic Exercise with Manual Lymphatic Drainage in Chronic Venous Insufficiency Patients

Elif Sakızlı Erdal, Abdullah Özer, Tuba Saadet Devecı Bulut, Özlem Gülbahar, Emetullah Cindil, İlke Keser. Lymphat Res Biol. 2025 Nov 22.

Background: This study aimed to examine the effects of aerobic exercise added to manual lymphatic drainage (MLD) on venous hemodynamics, inflammatory-vascularization markers, local tissue water percentages (LTW%), calf muscle endurance, exercise capacity, and quality of life (QoL) in patients with chronic venous insufficiency (CVI).
Methods: Participants were randomly assigned to one of two groups: (1) MLD group, which received MLD 5 days per week, and (2) MLD + aerobic exercise group, which received the same MLD plus aerobic exercise (30-minute walking sessions, three times per week) for 6 weeks. Venous hemodynamics was evaluated using Doppler ultrasonography. Inflammatory-vascularization markers, such as interleukin-6, vascular endothelial growth factor-A (VEGF-A), and some blood values were examined. LTW%, calf muscle endurance, exercise capacity, and QoL were evaluated with MoistureMeterD device, heel-rise test, 6-minute walk test (6MWT), and Venous Insufficiency Epidemiological and Economic Study on Quality-of-Life Questionnaire/Symptoms (VEINES-QOL/Sym), respectively.
Results: There was a significant increase in venous blood flow in the right great saphenous vein (GSV), VEGF-A, and QoL and a significant decrease in the diameter of the right GSV, monocytes, and LTW% in both groups. However, there was no superiority between groups. There was a significant increase in calf muscle endurance and exercise capacity in the group that added aerobic exercise compared to the MLD group (p < 0.05).
Conclusions: Since positive effects of MLD on venous flow, edema, and QoL have been found, MLD can be used in physiotherapy programs for CVI. Adding aerobic exercise to MLD is an effective treatment for CVI by increasing calf muscle endurance and exercise capacity, in addition to these positive effects.:10.1177/15578585251396848

Compression sleeves for prevention and treatment of breast cancer-related lymphedema: a systematic review and meta-analysis

Haifeng Cheng, Jianmei Gong, Lin Yu, Xiaoyu Feng, Wenna Ou, Huan Wang, Hongjing Zhong, En Ming Zhang. Breast Cancer Res Treat. 2025 Dec 13.

BACKGROUND: Compression sleeves are widely used for breast cancer-related lymphedema, but evidence on their effectiveness of prevention and treatment in volume reduction is limited.
OBJECTIVE: To compare the effects of compression sleeves and conventional care on breast cancer-related lymphedema, providing evidence-based support for clinical application.
METHODS: A systematic search of 9 databases was conducted up to June 9, 2025. Meta-analysis was performed using RevMan 5.4, and evidence quality was assessed with GRADE profiler 3.6.
RESULTS: 1532 patients were included. Compression sleeves significantly reduced lymphedema incidence post-surgery (P =0 .02) and edema volume/circumference (P <0 .001), and improved shoulder flexion (P =0.02). No significant effects were seen on shoulder abduction (P =0 .18), subjective symptoms (P =0.62), or quality of life (P = 0.32). Evidence quality was moderate for incidence and volume/circumference reduction, and low for other outcomes.
CONCLUSION: This meta-analysis shows that compression sleeves reduce lymphedema incidence and volume/circumference, and improve shoulder flexion. They should be considered in lymphedema management, though further research is needed for other outcomes.:10.1007

Cancer-related lymphedema educational needs disparities and optimization strategies

Sen Li, Guorui Zhao, Jie Long, Xiang Liu, Jiali Xu, Si Wu, Gaoming Liu. Nurse Educ Pract. 2025 Dec 18.

AIM: Identify distinct knowledge, attitude and practice (KAP) profiles and teaching preferences among healthcare workers (HCWs) and explore barriers to implementing cancer-related lymphedema (CRL) management services.
BACKGROUND: HCWs play a crucial role in the early prevention and management of CRL. However, existing research on their KAP has largely relied on scale-based total score approaches, which overlook individual heterogeneity. Meanwhile, on the practical side, there is a lack of a systematic environment conducive to supporting HCWs in lymphedema services.
DESIGN: Cross-sectional design.
METHOD: This study surveyed 1130 healthcare workers from 21 Chinese hospitals between December 2024 and January 2025. Latent profile analysis profiled KAP-based subgroups, whose predictive factors and learning method preferences were analyzed using generalized linear mixed models and DCAT. Barriers to service implementation were explored via latent Dirichlet allocation.
RESULTS: Three latent class profiles were identified: low-level, medium-level and high-level KAP. Education, experience in CRL management, professional title and department significantly influenced the KAP categories. Preferences for instructional strategies varied across profiles: Groups 1 and 2 favored structured instruction, whereas Group 3 preferred methods enriched with interactive elements. Thematic analysis identified several key barriers to lymphedema service implementation by HCWs, including resource investment, public awareness, medical security coverage, etc.
CONCLUSIONS: Our findings reveal heterogeneous KAP profiles and distinct learning method preferences among HCWs. This heterogeneity suggests a potential direction for developing stratified training tailored to specific needs or competency levels. Future optimization of the lymphedema care environment requires multifaceted interventions at the policy, regulatory, staffing and patient levels.:10.1016/j.nepr.2025.104689

Effect of Advanced Pneumatic Compression Devices in the Treatment of Lymphedema: A Systematic Review and Meta-Analyses

D Panchik, D Klepper, K Knecht, J Pron, M Schuller, V Chinchilli, A Cox, J Hornberger, S Letnaunchyn, Lymphology. 2025.

Lymphedema is a chronic, progressive impairment of the lymphatic system that can impact activities and quality of life. Research regarding conservative management of lymphedema primarily consists of complete decongestive therapy (CDT) and compression devices intended to promote lymphatic and venous return. Advanced pneumatic compression devices (APCDs) contain multiple programmable sleeves designed to mimic manual lymph drainage at home. This study aims to determine the effectiveness of APCDs in the treatment of lymphedema through the completion of a systematic review and meta-analysis. A systematic search of five databases was conducted, spanning the years 2010-2021. Only experimental designs of moderate or strong quality were chosen and final review set consists of twelve articles. APCDs are found to be effective for lymphedema treatment based on differences in pre- and post-intervention limb volumes and patient-reported outcomes. Two meta-analyses evaluated the impact of APCDs on both rates of cellulitis and manual therapy. Both analyses demonstrated significant decreases in rates after the APCD interventions. The data showed consistent reduction of limb volume and improved patient-reported outcomes, indicating that APCDs are generally effective as a complementary intervention to CDT in the maintenance phase of lymphedema treatment.

From Mobility to Management: A Scoping Review on Exercise in Breast Cancer-Related Lymphedema

Cansu Sahbaz Pirincci, Hasan Gercek, Emine Cihan, Elif Dilara Durmaz, Zübeyir Sari. Clin Breast Cancer. 2025 Nov 28.-130.

PURPOSE: Breast cancer-related lymphedema (BCRL) is a prevalent complication that adversely affects survivors’ physical function and quality of life. Exercise is increasingly used in BCRL management, yet the diversity in exercise types and lack of standardization present challenges for clinical implementation. This scoping review aimed to systematically map and synthesize the available literature on exercise interventions for BCRL, focusing on the types of exercises used, their frequency and duration, and their effects on clinical and functional outcomes.
METHODS: Studies were included if they were randomized or non-randomized controlled trials involving adult women with BCRL, evaluated at least one lymphedema-related outcome, and were published in English within the last 10 years. A comprehensive search was conducted in PubMed, Scopus, Web of Science, PEDro, and CINAHL databases using MeSH terms. Data were extracted on study design, sample size, exercise type, frequency and duration, and outcome measures.
RESULTS: Out of 974 records, 21 studies met the inclusion criteria. Exercises examined included resistance, aerobic, aquatic, Pilates, and scapulothoracic stabilization. Most interventions were 6 to 12 weeks in duration and applied 2 to 5 times per week. Exercise was found to be effective in reducing edema volume and severity, improving range of motion, pain, function, and quality of life, both independently and alongside CDT.
CONCLUSION: Exercise is a safe and effective intervention for BCRL management. However, variability in exercise protocols highlights the need for standardized recommendations. Future studies should aim to determine optimal parameters to guide clinical decision-making.:10.1016/j.clbc.2025.11.011

Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis

Junzhe Chen, Xiyao Feng, Yan Zhou, Yun Wang, Shune Xiao, Chengliang Deng. Front Oncol. 2025 Nov 26

Download full paper

Effect of home exercise on prevention and treatment of lymphedema in breast cancer patients

Hui Yin, Weiwei Wu, Qungui Zhang, Fangfang Xie. Front Oncol. 2025 Dec 16

Download full paper

A co-design of a digital platform to support self-management of breast cancer-related lymphoedema

Navaz Naghavi, Monique Bareham, Olivia Cook, Neil B. Piller, Raymond Javan Chan, Lisa Beatty, Kerry A. Sherman, Emma Kemp, Ganessan Kichenadasse, Richard L. Reed, Matthew P. Wallen, Richard Woodman, Billingsley Kaambwa, Bogda Koczwara. Support Care Cancer. 2026 Jan 6.

Download full paper

The effect of prolonged complex decongestive therapy for lower limb secondary lymphedema

Kotaro Suehiro, Takasuke Harada, Yuriko Takeuchi, Takahiro Mizoguchi, Hiroshi Kurazumi, Mototsugu Shimokawa, Kimikazu Hamano. J Vasc Surg Venous Lymphat Disord. 2026 Jan 7:102444.

Download full paper

The effects of adding physiotherapy to compression therapy on function and oedema in chronic venous insufficiency

Noemí Moreno-Segura, Mario Mateo-Martínez, Mariana Sánchez-Barbadora, Rodrigo Martín-San Agustín. Vasa. 2026 Jan 19

Download full paper

Self-management of lower limb lymphedema at home following gynecologic cancer surgery: a qualitative study of women’s experiences and challenges

Yuting Tan, Cong Yu, Xiuzhen Mo, Chenghua Sun, Huina Gao, Shufen Song, Qian Zhao. Front Psychol. 2026 Jan 8.

Download full paper

Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial

Barbara A. Murphy, Derek K. Smith, Cristina M. Kline-Quiroz, Katrina M. Jensen, Ammar W. Sukari, Mihir K. Bhayani, Vikas Mehta, Harry Quon, Jennifer L. Shah, Christopher D. Willey, Neal E. Dunlap, Hoon K. Lee, Joseph M. Aulino, Sheila H. Ridner. Head Neck. 2026 Jan 23.

Download full paper

The efficacy of complex decongestive therapy in the treatment of lymphedema associated with endometrial and cervical cancer: evaluation of sensation and balance

Emine Cihan, Cansu Sahbaz Pirincci. Support Care Cancer. 2026 Jan 22

Download full paper